GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2853.5000 -83.00 (-2.83%)
NSE Aug 04, 2025 11:07 AM
Volume: 55,054
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
2853.50
-2.83%
buy
by ICICI Securities Limited
Target: 2640 | Target met
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Phar.. has an average target of 2610.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market trades higher, MCX's Q1 net profit surges 83.2% YoY to Rs 203.1 crore
Trendlyne Marketwatch | 04 Aug 2025, 10:47AM
Five Interesting Stocks Today - August 1, 2025
The Baseline | 01 Aug 2025
Chart of the Week: Global currencies gain ground on the US dollar, Indian rupee declines
The Baseline | 31 Jul 2025